Nurix Therapeutics, Inc.(NRIX)Stock Performance & ReturnsNASDAQ
Returns, drawdowns and benchmark comparison
Peer Comparison
Relative scale, growth, and profitability vs sector peers
| Ticker | Market Cap | P/E Ratio | Revenue Growth | Net Margin | EPS | ROE | Debt/Equity | Dividend Yield | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|---|---|
NRIX | 2.85 B | 10.28x | 8426.30% | 42.01% | $2.54 | 43.99% | 0.07x | 0.00% | $28.23 | $10.15 |
DYN | 3.04 B | - | - | 0.00% | -$3.30 | -81.57% | 0.33x | 0.00% | $27.31 | $14.00 |
DNLI | 3.03 B | - | - | 0.00% | -$2.84 | -54.93% | 0.05x | 0.00% | $27.30 | $13.75 |
RCUS | 2.99 B | - | -74.40% | 0.00% | -$3.91 | -90.82% | 0.51x | 0.00% | $31.74 | $16.41 |
CELC | 2.94 B | - | - | 0.00% | -$4.31 | -1433.70% | - | 0.00% | $151.02 | $53.54 |
Peer Valuation & Performance Analysis
Peer group analysis for Nurix Therapeutics, Inc. (NRIX) compared to its primary competitors (including DYN, DNLI, RCUS) reveals distinct metrics. NRIX trades at a valuation premium compared to its competitors, with a P/E ratio of 10.3x versus the peer average of -7.9x (representing a -230% premium). This indicates that the market expects superior growth or commands a quality premium for NRIX. In terms of growth, NRIX's revenue growth of 8426.3% exceeds the peer average of -74.4%, highlighting its competitive strength and market share gains. Additionally, it boasts superior profitability with a net margin of 42.0% compared to the peer average of 0.0%, demonstrating strong cost controls and pricing power.
Peer Performance Rankings
Ranking comparison across key performance metrics
P/E Ratio (Lower is Better)
Revenue Growth
Net Profit Margin
Financial Rankings Summary
• NRIX ranks #1 in P/E ratio, #1 in revenue growth, and #1 in profit margins
• Average ranking: #1 - 🎯 Top-tier fundamentals relative to peer group
• Rankings based on actual financial data from company reports
Historical Trading Data
Price and volume data with customizable timeframes
Showing 15 of 15 trading sessions from the last 15 days
| Date | Open | High | Low | Close | Volume | Daily Change |
|---|---|---|---|---|---|---|
| 2026-10-20 | $24.92 | $26.34 | $24.71 | $26.10 | 3,979,800 | +4.69% |
| 2026-10-19 | $24.57 | $25.29 | $24.38 | $24.93 | 3,064,100 | +2.09% |
| 2026-10-16 | $24.89 | $25.36 | $24.27 | $24.42 | 4,318,300 | -2.12% |
| 2026-10-15 | $23.67 | $25.14 | $23.61 | $24.95 | 3,753,400 | +5.41% |
| 2026-10-14 | $22.01 | $24.01 | $21.40 | $23.67 | 3,820,700 | +6.96% |
| 2026-10-13 | $22.16 | $23.24 | $21.75 | $22.13 | 4,680,800 | -0.14% |
| 2026-10-12 | $22.27 | $22.57 | $22.02 | $22.16 | 2,850,900 | -0.85% |
| 2026-10-09 | $22.04 | $23.23 | $21.23 | $22.35 | 1,525,100 | +0.63% |
| 2026-10-08 | $22.49 | $22.60 | $21.55 | $22.21 | 2,344,900 | -2.29% |
| 2026-10-07 | $22.43 | $23.10 | $22.18 | $22.73 | 1,631,800 | +0.58% |
| 2026-10-06 | $23.06 | $23.06 | $22.10 | $22.60 | 1,154,200 | -1.22% |
| 2026-10-05 | $22.81 | $23.31 | $22.43 | $22.88 | 1,006,500 | -0.48% |
| 2026-10-02 | $23.72 | $23.75 | $22.85 | $22.99 | 815,500 | -1.50% |
| 2026-10-01 | $23.60 | $23.98 | $23.21 | $23.34 | 1,334,900 | -1.56% |
| 2026-09-30 | $23.85 | $23.94 | $23.34 | $23.71 | 2,010,700 | +0.15% |
Explore More Analysis for NRIX
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.